246 related articles for article (PubMed ID: 31535408)
21. GR SUMOylation and formation of an SUMO-SMRT/NCoR1-HDAC3 repressing complex is mandatory for GC-induced IR nGRE-mediated transrepression.
Hua G; Paulen L; Chambon P
Proc Natl Acad Sci U S A; 2016 Feb; 113(5):E626-34. PubMed ID: 26712002
[TBL] [Abstract][Full Text] [Related]
22. GATA3 in the urinary bladder: suppression of neoplastic transformation and down-regulation by androgens.
Li Y; Ishiguro H; Kawahara T; Miyamoto Y; Izumi K; Miyamoto H
Am J Cancer Res; 2014; 4(5):461-73. PubMed ID: 25232488
[TBL] [Abstract][Full Text] [Related]
23. Glucocorticoid repression of inflammatory gene expression shows differential responsiveness by transactivation- and transrepression-dependent mechanisms.
King EM; Chivers JE; Rider CF; Minnich A; Giembycz MA; Newton R
PLoS One; 2013; 8(1):e53936. PubMed ID: 23349769
[TBL] [Abstract][Full Text] [Related]
24. Membrane-initiated nuclear trafficking of the glucocorticoid receptor in hypothalamic neurons.
Rainville JR; Weiss GL; Evanson N; Herman JP; Vasudevan N; Tasker JG
Steroids; 2019 Feb; 142():55-64. PubMed ID: 29242167
[TBL] [Abstract][Full Text] [Related]
25. Glucocorticoid Receptor Transactivation Is Required for Glucocorticoid-Induced Ocular Hypertension and Glaucoma.
Patel GC; Millar JC; Clark AF
Invest Ophthalmol Vis Sci; 2019 May; 60(6):1967-1978. PubMed ID: 31050723
[TBL] [Abstract][Full Text] [Related]
26. ZKSCAN3 promotes bladder cancer cell proliferation, migration, and invasion.
Kawahara T; Inoue S; Ide H; Kashiwagi E; Ohtake S; Mizushima T; Li P; Li Y; Zheng Y; Uemura H; Netto GJ; Ishiguro H; Miyamoto H
Oncotarget; 2016 Aug; 7(33):53599-53610. PubMed ID: 27447553
[TBL] [Abstract][Full Text] [Related]
27. Differential regulation of bladder cancer growth by various glucocorticoids: corticosterone and prednisone inhibit cell invasion without promoting cell proliferation or reducing cisplatin cytotoxicity.
Ishiguro H; Kawahara T; Zheng Y; Kashiwagi E; Li Y; Miyamoto H
Cancer Chemother Pharmacol; 2014 Aug; 74(2):249-55. PubMed ID: 24880571
[TBL] [Abstract][Full Text] [Related]
28. Effects of α
Nagata Y; Kawahara T; Goto T; Inoue S; Teramoto Y; Jiang G; Fujimoto N; Miyamoto H
Am J Cancer Res; 2020; 10(12):4386-4398. PubMed ID: 33415006
[TBL] [Abstract][Full Text] [Related]
29. Glucocorticoid regulation of c-fos, c-jun and transcription factor AP-1 in the AtT-20 corticotrope cell.
Autelitano DJ
J Neuroendocrinol; 1994 Dec; 6(6):627-37. PubMed ID: 7894465
[TBL] [Abstract][Full Text] [Related]
30. Thiazolidinedione effects on glucocorticoid receptor-mediated gene transcription and differentiation in osteoblastic cells.
Johnson TE; Vogel R; Rutledge SJ; Rodan G; Schmidt A
Endocrinology; 1999 Jul; 140(7):3245-54. PubMed ID: 10385421
[TBL] [Abstract][Full Text] [Related]
31. Glucocorticoid regulation of alkaline phosphatase, osteocalcin, and proto-oncogenes in normal human osteoblast-like cells.
Subramaniam M; Colvard D; Keeting PE; Rasmussen K; Riggs BL; Spelsberg TC
J Cell Biochem; 1992 Dec; 50(4):411-24. PubMed ID: 1469072
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of glucocorticoid-induced changes of Na(+), K(+)-ATPase in rat lens by a glucocorticoid receptor antagonist RU486.
Xie GL; Yan H; Lu ZF
Exp Eye Res; 2010 Oct; 91(4):544-9. PubMed ID: 20637751
[TBL] [Abstract][Full Text] [Related]
33. The anticancer plant triterpenoid, avicin D, regulates glucocorticoid receptor signaling: implications for cellular metabolism.
Haridas V; Xu ZX; Kitchen D; Jiang A; Michels P; Gutterman JU
PLoS One; 2011; 6(11):e28037. PubMed ID: 22132201
[TBL] [Abstract][Full Text] [Related]
34. Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction.
Ronacher K; Hadley K; Avenant C; Stubsrud E; Simons SS; Louw A; Hapgood JP
Mol Cell Endocrinol; 2009 Feb; 299(2):219-31. PubMed ID: 19007848
[TBL] [Abstract][Full Text] [Related]
35. Vanadate increases glucocorticoid receptor-mediated gene expression: a novel mechanism for potentiation of a steroid receptor.
Li Calzi S; Periyasamy S; Li DP; Sánchez ER
J Steroid Biochem Mol Biol; 2002 Jan; 80(1):35-47. PubMed ID: 11867262
[TBL] [Abstract][Full Text] [Related]
36. Species-specific differences in the glucocorticoid receptor transactivation function upon binding with betamethasone-esters.
Tanigawa K; Nagase H; Ohmori K; Tanaka K; Miyake H; Kiniwa M; Ikizawa K
Int Immunopharmacol; 2002 Jun; 2(7):941-50. PubMed ID: 12188035
[TBL] [Abstract][Full Text] [Related]
37. Dexamethasone decreases xenograft response to Paclitaxel through inhibition of tumor cell apoptosis.
Pang D; Kocherginsky M; Krausz T; Kim SY; Conzen SD
Cancer Biol Ther; 2006 Aug; 5(8):933-40. PubMed ID: 16775428
[TBL] [Abstract][Full Text] [Related]
38. RGS6 is an essential tumor suppressor that prevents bladder carcinogenesis by promoting p53 activation and DNMT1 downregulation.
Yang J; Platt LT; Maity B; Ahlers KE; Luo Z; Lin Z; Chakravarti B; Ibeawuchi SR; Askeland RW; Bondaruk J; Czerniak BA; Fisher RA
Oncotarget; 2016 Oct; 7(43):69159-69172. PubMed ID: 27713144
[TBL] [Abstract][Full Text] [Related]
39. The steroid receptor antagonists RU40555 and RU486 activate glucocorticoid receptor translocation and are not excreted by the steroid hormones transporter in L929 cells.
Pariante CM; Pearce BD; Pisell TL; Su C; Miller AH
J Endocrinol; 2001 May; 169(2):309-20. PubMed ID: 11312148
[TBL] [Abstract][Full Text] [Related]
40. Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor.
Hsu JW; Hsu I; Xu D; Miyamoto H; Liang L; Wu XR; Shyr CR; Chang C
Am J Pathol; 2013 May; 182(5):1811-20. PubMed ID: 23499463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
